Highlighting the urgent need for the development of treatment strategies targeting EWS metastatic disease, an epidemiological study of over 800 EWS and EWS-like tumor cases identified that 35% of patients had detectable metastatic disease at presentation (2). The gene discussed is EWSR1; the disease is metastatic neoplasm.